Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.49 +0.08 (+18.98%)
At close: Oct 21, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Operating Leases (2022 - 2023)

Updated

Pasithea Therapeutics (KTTA) posted Operating Leases of $210,817 for Q3 2023, down 70.9% from $724,386 a year earlier and down 17.7% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Operating Leases (2022 - 2023) Analysis & Trends

At the end of FY2022, Pasithea Therapeutics' Operating Leases came in at $344,021.

  • According to Business Quant data, Operating Leases for the three prior quarters was $256,084 (Q2 2023), $300,480 (Q1 2023) and $344,021 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Pasithea Therapeutics 15.54 Mn -139.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 210,817.00
Jun 30, 2023 256,084.00
Mar 31, 2023 300,480.00
Dec 31, 2022 344,021.00
Sep 30, 2022 724,386.00
Jun 30, 2022 358,245.00
API Access

Pasithea Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=KTTA&period=max&api_key=YOUR_API_KEY